Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease

(MedPage Today) -- SAN DIEGO -- Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in patients with hemoglobin SC, a milder form of sickle cell disease (SCD), a Ghanaian randomized phase II...